Hormone replacement therapy and breast cancer morbidity, mortality and recurrence

Author： Kenemans P. Scheele F. Burger C.W.

Publisher： Elsevier

ISSN： 0301-2115

Source： European Journal of Obstetrics and Gynecology and Reproductive Biology, Vol.71, Iss.2, 1997-02, pp. : 199-203

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Breast cancer in premenopausal women: recurrence and survival rates and relationship to hormone replacement therapy

By Durna EM Heller GZ Leader LR Sjoblom P Eden JA Wren BG

Climacteric, Vol. 7, Iss. 3, 2004-09 ,pp. : 284-291

Informa Healthcare

Access to resources Recommend Favorite

The truth about hormone replacement therapy and breast cancer

By Priyadarshi Sewanti Fernandez Imelyn M Voige Hayley Del Priore Giuseppe

Expert Review of Obstretrics and Gynecology, Vol. 2, Iss. 1, 2007-01 ,pp. : 25-29

Informa Healthcare

Access to resources Recommend Favorite

Hormone replacement therapy and cancer

By Genazzani A. R. Gadducci A. Gambacciani M.

Climacteric, Vol. 4, Iss. 3, 2001-09 ,pp. : 181-193

Informa Healthcare

Access to resources Recommend Favorite

Evolution of breast cancer incidence in relation to hormone replacement therapy use in Belgium

By Antoine C. Ameye L. Moreau M. Paesmans M. Rozenberg S.

Climacteric, Vol. 14, Iss. 4, 2011-08 ,pp. : 464-471

Informa Healthcare

Access to resources Recommend Favorite

Impact of menopausal hormone. Replacement therapy on prognostic characteristics of breast cancer.

By Bonnier P. Sakr R. Bessenay F. Lejeune C. Charpin C. Martin P.M. Piana L.

Gynecology Obstetrique & Fertilite, Vol. 28, Iss. 10, 2000-10 ,pp. : 745-753

Elsevier

Access to resources Recommend Favorite